PH17576A - Indole thromboxane synthetase inhibitors,pharmaceutical compositions containing them and method of use thereof - Google Patents

Indole thromboxane synthetase inhibitors,pharmaceutical compositions containing them and method of use thereof

Info

Publication number
PH17576A
PH17576A PH26617A PH26617A PH17576A PH 17576 A PH17576 A PH 17576A PH 26617 A PH26617 A PH 26617A PH 26617 A PH26617 A PH 26617A PH 17576 A PH17576 A PH 17576A
Authority
PH
Philippines
Prior art keywords
indole
pharmaceutical compositions
compositions containing
synthetase inhibitors
thromboxane synthetase
Prior art date
Application number
PH26617A
Other languages
English (en)
Inventor
Peter Edward Cross
Roger Peter Dickinson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PH17576A publication Critical patent/PH17576A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
PH26617A 1980-12-15 1981-12-11 Indole thromboxane synthetase inhibitors,pharmaceutical compositions containing them and method of use thereof PH17576A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8040081 1980-12-15

Publications (1)

Publication Number Publication Date
PH17576A true PH17576A (en) 1984-10-01

Family

ID=10517993

Family Applications (1)

Application Number Title Priority Date Filing Date
PH26617A PH17576A (en) 1980-12-15 1981-12-11 Indole thromboxane synthetase inhibitors,pharmaceutical compositions containing them and method of use thereof

Country Status (22)

Country Link
US (1) US4363912A (no)
EP (1) EP0054417B1 (no)
JP (1) JPS57181082A (no)
KR (1) KR830007552A (no)
AR (1) AR229110A1 (no)
AU (1) AU525296B2 (no)
CA (1) CA1143737A (no)
CS (1) CS228527B2 (no)
DD (1) DD202290A5 (no)
DE (1) DE3167879D1 (no)
DK (1) DK552581A (no)
ES (1) ES8308872A1 (no)
FI (1) FI814003L (no)
GR (1) GR76355B (no)
IE (1) IE51949B1 (no)
IL (1) IL64534A0 (no)
NO (1) NO814264L (no)
PH (1) PH17576A (no)
PL (1) PL133634B1 (no)
PT (1) PT74123B (no)
YU (1) YU293481A (no)
ZA (1) ZA818665B (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS229934B2 (en) * 1981-07-07 1984-07-16 Pfizer Production method subst.indolylacryte acid derivative
US4478842A (en) * 1981-11-19 1984-10-23 Ciba-Geigy Corporation N-Substituted-2-pyridylindoles
US4460777A (en) * 1981-11-19 1984-07-17 Ciba-Geigy Corporation N-Substituted-2-pyridylindoles
US4511573A (en) * 1983-05-17 1985-04-16 Ciba-Geigy Corporation 3-Substituted-2-(heteroaryl) indoles
US4536505A (en) * 1983-05-17 1985-08-20 Ciba-Geigy Corporation Certain N-(pyridyl) indoles
GB8524157D0 (en) * 1984-10-19 1985-11-06 Ici America Inc Heterocyclic amides
US4609733A (en) * 1984-12-27 1986-09-02 Ciba-Geigy Corporation 3-keto-substituted-N-pyridylindoles
GB8609175D0 (en) * 1986-04-15 1986-05-21 Ici America Inc Heterocyclic carboxamides
OA11622A (en) 1998-03-31 2004-09-16 Inst For Pharm Discovery Inc Substituted indolealkanoic acids.
TNSN99224A1 (fr) 1998-12-01 2005-11-10 Inst For Pharm Discovery Inc Methodes de reduction des niveaux de glucose et triglyceride en serum et pour suppression de l'antigenese utilisant les acides la indolealkanoique
US20010044437A1 (en) * 2000-01-14 2001-11-22 Dale Robinson Methods for reducing uric acid levels
US7348351B2 (en) * 2002-12-10 2008-03-25 Wyeth Substituted 3-alkyl and 3-arylalkyl 1H-indol-1yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
GB0324763D0 (en) * 2003-10-23 2003-11-26 Oxagen Ltd Use of compounds in therapy
PL2046740T3 (pl) 2006-07-22 2012-10-31 Oxagen Ltd Związki o aktywności antagonisty CRTH2
CN101918360A (zh) * 2007-09-24 2010-12-15 阿勒根公司 具有1-磷酸-鞘氨醇(s1p)受体生物学活性的带芳基或者杂芳基基团的吲哚化合物
MX2010007833A (es) * 2008-01-18 2010-08-11 Oxagen Ltd Compuestos que tienen actividad antagonista de crth2.
US7750027B2 (en) * 2008-01-18 2010-07-06 Oxagen Limited Compounds having CRTH2 antagonist activity
JP2011509991A (ja) * 2008-01-22 2011-03-31 オキサジェン リミテッド Ｃｒｔｈ２アンタゴニスト活性を有する化合物
WO2009093026A1 (en) 2008-01-22 2009-07-30 Oxagen Limited Compounds having crth2 antagonist activity
GB201322273D0 (en) 2013-12-17 2014-01-29 Atopix Therapeutics Ltd Process
GB201407807D0 (en) * 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form
GB201407820D0 (en) * 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5173M (no) * 1966-02-11 1967-06-19
FR7337M (no) * 1968-01-11 1969-10-13
GB2045244B (en) 1979-03-07 1983-01-26 Pfizer Ltd 3-1-(imidazolylalkyl) indoles
US4322533A (en) * 1980-03-17 1982-03-30 Lesher George Y 1H-Indole-2,3-dione derivatives

Also Published As

Publication number Publication date
PL234253A1 (en) 1983-05-23
IL64534A0 (en) 1982-03-31
KR830007552A (ko) 1983-10-21
AR229110A1 (es) 1983-06-15
PL133634B1 (en) 1985-06-29
IE51949B1 (en) 1987-04-29
ES507960A0 (es) 1983-10-01
PT74123B (en) 1983-12-19
DK552581A (da) 1982-06-16
AU7848881A (en) 1982-06-24
CA1143737A (en) 1983-03-29
FI814003L (fi) 1982-06-16
GR76355B (no) 1984-08-06
JPS57181082A (en) 1982-11-08
DD202290A5 (de) 1983-09-07
IE812928L (en) 1982-06-15
YU293481A (en) 1984-10-31
EP0054417A1 (en) 1982-06-23
ES8308872A1 (es) 1983-10-01
CS228527B2 (en) 1984-05-14
DE3167879D1 (en) 1985-01-31
EP0054417B1 (en) 1984-12-19
AU525296B2 (en) 1982-10-28
US4363912A (en) 1982-12-14
PT74123A (en) 1982-01-01
ZA818665B (en) 1982-10-27
NO814264L (no) 1982-06-16

Similar Documents

Publication Publication Date Title
DE3165703D1 (en) Heterocyclic thromboxane synthetase inhibitors, processes for their preparation, and pharmaceutical compositions containing them
PH17576A (en) Indole thromboxane synthetase inhibitors,pharmaceutical compositions containing them and method of use thereof
GB2038821B (en) N-(phenoxyalkyl)imidazoles as selective inhibitors of the thromboxane synthetase enzyme pharmaceutical compositions thereof and process for their preparation
DE2960547D1 (en) 3-(imidazol-1-ylalkyl)indoles as selective inhibitors of thromboxane synthetase,pharmaceutical compositions thereof, and methods for preparing them
PH22764A (en) New bicyclic compounds, method of use and pharmaceutical formulations containing such compounds
PH17460A (en) Hydantoin derivatives and pharmaceutical compositions containing the same
IL61936A (en) Derivatives of cba2 and pharmaceutical compositions containing them
PT70707A (en) Process for preparing n-benzyl-imidazoles as selective inhibitors of the thromboxane synthetase enzyme and pharmaceutical compositions
PH15877A (en) Novel n-heterocyclyl-4-piperidiamines,pharmaceutical composition containing same and method of use
CY1406A (en) Substituted dipeptides, processes for their preparation and pharmaceutical compositions containing them and their use in the inhibition of enkephalinase
CS410491A3 (en) Heterocyclic derivatives, process of their preparation and pharmaceutical containing them
PH18091A (en) Novel spiro-oxazolidindiones,pharmaceutical compositions containing same and method of use thereof
PH16249A (en) Imidazoline derivatives,its pharmaceutical composition and method of use
PH18979A (en) Banzazepine derivatives,their pharmaceutical compositions and method of use
DE3275545D1 (en) Indole thromboxane synthetase inhibitors, processes for their preparation, and pharmaceutical compositions containing them
PH17390A (en) Imidazolylphenyl amidines,pharmaceutical compositions containing same and use thereof
IL63423A0 (en) 9-amino-1-hydroxyoctahydrobenzo(c)quinoline derivatives and pharmaceutical compositions containing them
DE3062101D1 (en) Imidazole thromboxane synthetase inhibitors, processes for preparing them, and pharmaceutical compositions containing them
ZA824789B (en) Indole thomboxane synthetase inhibitors, processes for their preparation, and pharmaceutical compositions containing them
GB8309779D0 (en) Thromboxane synthetase inhibitors
PH23486A (en) Indole analogs of mevalonolactone,pharmaceutical compositions containing the same and method of use thereof
AR243177A1 (es) Procedimiento para la obtencion de 1-alquilo-2-piridiloindoles sus n-oxidos y sus sales.
DE3160987D1 (en) Benzodiazepine derivatives, intermediates and processes for preparing them, their use and pharmaceutical compositions containing them
DE3160986D1 (en) Benzodiazepine derivatives, intermediates and processes for preparing them, their use and pharmaceutical compositions containing them
IL62167A (en) Azolyl derivatives of phenoxyaminopropanols,intermediates and processes for their manufacture and pharmaceutical compositions containing them